Human Vaccines & Immunotherapeutics
Landes Bioscience · United States
Metrics
- Impact factor
- 4.2+0.7 Clarivate JCR
- WoS quartile
- Q2 Clarivate JCR, best category
- SJR
- 1.094Q1 SCImago
- h-index
- 43
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 3.68 last 2 years
- Articles per year
- 547
- Self-citation
- 9.8%
- Fee (APC), est.
- $3,333 estimated, check the journal
About this journal
- ISSN
- 2164-5515 (print) · 2164-554X (online)
- Publisher
- Landes Bioscience
- Country
- United States · Northern America
- Indexed in
- SCIE
- Access
- Gold OA · 100% gold OA
- Original research
- 84.1%
- Subject areas
- Immunology and Microbiology, Medicine, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Biotechnology & Applied Microbiology, Immunology
- Common topics
- Medicine, Biology, Immunology, Virology, Pathology
Similar journals
- Q2WoS
Journal of Immunology
Impact factor 4h-index 345SJR 1.44 - Q2WoS
Journal of Bacteriology
Impact factor 3.8h-index 222SJR 1.40 - Q2WoS
Infection and Immunity
Impact factor 3.4h-index 204SJR 1.17 - Q2WoS
Aids
Impact factor 2.9h-index 203SJR 1.14 - Q2WoS
Applied Microbiology and Biotechnology
Impact factor 4.7h-index 198SJR 1.01 - Q2WoS
European Journal of Immunology
Impact factor 4.1h-index 187SJR 1.67
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals